Natixis »

Supernus Pharmaceuticals shares owned by Natixis

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Natixis

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 85k 51.69
2020-12-31 $1.2M 49k 25.16

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Energy Transfer Com Ut Ltd Ptn (ET)
Amazon (AMZN)
eBay (EBAY)

View all positions for Natixis

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals